Skip to main content
. 2019 Apr 30;19(6):5397–5405. doi: 10.3892/mmr.2019.10210

Figure 6.

Figure 6.

miR-136-5p reversed the promoting effects of NORAD in NSCLC cells. (A) Cell proliferation and (B) glycolysis were examined following co-transfection with NORAD nc/si1 and miR-136-5p nc/inhibitor in A549 cells. *P<0.05 vs. si-NC+inhibitor nc group; #P<0.05 vs. si-NC+miR-136-5p inhibitor group; &P<0.05 vs. si-NORAD+ inhibitor nc group. (C) Cell proliferation and (D) glycolysis were detected following co-transfection with NORAD nc/over and miR-136-5p nc/mimics in H460 cells. *P<0.05 vs. NC+mimic nc group; #P<0.05 vs. NC+miR-136-5p mimic group; &P<0.05 vs. pNORAD+mimic nc group. NORAD, non-coding RNA activated by DNA damage; NSCLC, non-small-cell lung cancer.